One Platform. Multiple Teams. Smarter Decisions.
Beacon connects the intelligence needed across the investment process, helping specialist teams evaluate opportunities from first screen through diligence, decision and portfolio monitoring.
Investment Teams
How Beacon Helps Investment Teams
✓ Screen companies, platforms and assets against the full competitive landscape
✓ Identify differentiated opportunities and hidden competitors earlier
✓ Compare development maturity, momentum and strategic positioning
✓ Build stronger investment theses with connected scientific and commercial evidence
Scientific & Technical Diligence
How Beacon Helps Scientific & Technical Diligence Teams
✓ Validate targets, mechanisms, modalities and preclinical evidence in context
✓ Benchmark asset quality against successful, failed and competing approaches
✓ Assess translational assumptions using connected preclinical and clinical intelligence
✓ Trace conclusions back to source evidence for deeper expert review
Market & Commercial Diligence
How Beacon Helps Market & Commercial Diligence Teams
✓ Map market structure, competitor pipelines and areas of crowding or whitespace
✓ Track company activity, financing, partnerships, licensing and M&A signals
✓ Benchmark comparable deals to inform valuation assumptions
✓ Connect commercial momentum with the underlying scientific and clinical landscape
Portfolio & Value Creation
How Beacon Helps Portfolio & Value Creation Teams
✓ Monitor competitor milestones, new entrants and evidence that could change an asset thesis
✓ Identify partnering, positioning and pipeline opportunities for portfolio companies
✓ Support management teams with data-backed views of differentiation and risk
✓ Track emerging technologies and strategic shifts across priority markets
Partners & Investment Committees
How Beacon Helps Partners & Investment Committees
✓ Review opportunities through a consistent, decision-grade evidence base
✓ Challenge key assumptions on differentiation, development risk and competition
✓ Compare opportunities objectively across targets, modalities and markets
✓ Make investment decisions with traceable intelligence that stands up to scrutiny
Why Leading Life Science Investors Choose Beacon
Beacon captures the scientific depth, context and traceability that generic databases and AI engines often miss, helping investors evaluate complex opportunities, reduce diligence blind spots and reach conviction with greater confidence.
Modality & Disease-Specific Datasets
Analyze the full competitive landscape. Includes the 20-30% of data AI engines miss.
Subject Matter Expert-Led Curation
Curated by scientists, trusted by strategists to deliver decision-grade intelligence
Holistic Preclinical & Clinical Data
From discovery to clinic, depth and context no generic platform can match.
Granular Ontologies & Modality-Specific Data
From “who is active” to “what wins” benchmark what drives differentiation.
Structured, AI-ready Data
Power your analytics and automation workflows. Gold-standard data in, gold-standard decisions out.
Why Generic Databases and AI Engines Fall Short
The difference is clear. Beacon delivers decision-grade intelligence designed specifically for drug development.
| What Matters | Generic Databases | AI Engines | Beacon |
| Landscape Completeness | Broad, but shallow | Highly variable; significant omissions | Access the full landscape, including the 20-30% others miss |
| Preclinical depth | Limited or absent | Largely missing from model outputs | Core strength, curated from grey literature upwards |
| Scientific granularity | Company, indication, phase of development | Unstructured narrative text | 90+ modality-specific filters and ontologies |
| Curation | Largely automated aggregation | None, model inference only | Curated by sector scientists, zero tolerance for errors |
| Consistency | Varies with refresh cycles and versioning | Answers vary between identical queries | Deterministic, the same query returns the same result |
| Defensibility | Partial sourcing; re-validation needed | Sources often missing, paraphrased or fabricated | 100% traceable, board and portfolio ready |
Are You Ready to See the Evidence Behind the Opportunity?
Validate differentiation, uncover hidden risk and build investment conviction with decision-grade life science intelligence.
Search